Cantabio Pharmaceuticals (CE) (CTBO)

Cantabio Pharmaceuticals Inc (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CTBO

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
21/06/2019	21:12	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
21/06/2019	21:09	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
21/06/2019	21:05	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
17/06/2019	19:20	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
24/05/2019	21:51	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
24/05/2019	21:36	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
15/05/2019	22:43	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
15/05/2019	22:39	Edgar (US Regulatory)	Information Statements (revised) (prer14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
08/05/2019	18:05	Edgar (US Regulatory)	Information Statements (revised) (prer14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
08/05/2019	17:55	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
10/04/2019	20:14	Edgar (US Regulatory)	Statement of Ownership: Private Transaction (sc 13e3)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
22/03/2019	18:25	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
21/03/2019	19:02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
14/12/2018	19:27	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
13/11/2018	17:56	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
15/10/2018	15:25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
11/10/2018	22:08	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
11/10/2018	22:05	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
11/10/2018	22:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
20/08/2018	20:55	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
15/08/2018	15:09	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
16/07/2018	11:02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
29/06/2018	15:54	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
08/06/2018	15:21	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
11/04/2018	15:33	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
20/02/2018	17:42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
14/02/2018	20:17	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
27/11/2017	17:41	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
14/11/2017	19:56	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)
14/08/2017	20:22	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTBO	Cantabio Pharmaceuticals Inc (CE)